Antiplatelet and antithrombogenic effects of suloctidil
- 1 June 1976
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 37 (2), 265-274
- https://doi.org/10.1016/0014-2999(76)90034-0
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Cyclic Nucleotide Phosphodiesterases: Properties, Activators, Inhibitors, Structure–Activity Relationships, and Possible Role in Drug DevelopmentJournal of Pharmaceutical Sciences, 1975
- Aggregation of blood platelets by biogenic amines and its inhibition by antiadrenergic and antiserotoninergic agentsBiochemical Pharmacology, 1974
- STUDIES ON THE ROLE OF CYCLIC AMP IN PLATELET FUNCTION*Annals of the New York Academy of Sciences, 1971
- LOW DOSES OF HEPARIN IN PREVENTION OF DEEP-VEIN THROMBOSISThe Lancet, 1971
- Method to Determine the Degree of ADP-Induced Platelet Aggregation in Circulating Rat Blood (‘Filter-loop Technique’)British Journal of Haematology, 1970
- EFFECT OF CLOFIBRATE ON PLATELET ECONOMY IN MANThe Lancet, 1967
- Platelet Behaviour and Drugs Used in Cardiovascular DiseaseCardiovascular Research, 1967
- EFFECT OF DIPYRIDAMOLE ON HUMAN PLATELET BEHAVIOURThe Lancet, 1965
- Comparative Effectiveness of Adenosine Analogues as Inhibitors of Blood-Platelet Aggregation and as Vasodilators in ManNature, 1965
- The aggregation of blood plateletsThe Journal of Physiology, 1963